Meeting
2021 Genitourinary Cancers Symposium
Baseline pathogenic mutations in non-AR/non-TP53 genes and prediction of response to high-dose testosterone.
Authors
Ellen Jaeger
Tulane University, New Orleans, LA
Ellen Jaeger , Sydney Caputo , Elisa Marie Ledet , Marcus W. Moses , Jodi Lyn Layton , Brian E. Lewis , Pedro C. Barata , A. Oliver Sartor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Advanced Disease
Track
Prostate Cancer - Advanced
Sub Track
Translational Research
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 146)
DOI
10.1200/JCO.2021.39.6_suppl.146
Abstract #
146
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Evaluation of ctDNA alterations in mCRPC patients with germline pathogenic mutations.
First Author: Malcolm Light
Poster
2019 ASCO Annual Meeting
AR changes in circulating-tumor DNA (ctDNA) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with high-dose testosterone.
First Author: Marcus W. Moses
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluation of ctDNA in patients with CRPC with pathogenic germline mutations in BRCA2.
First Author: Minqi Huang
Poster
2018 Genitourinary Cancers Symposium
Cell-free DNA (cfDNA) analysis and evaluation of BRAF amplifications and mutations in metastatic castration-resistant prostate cancer.
First Author: Peter Steinwald